1. Home
  2. HRMY vs STRA Comparison

HRMY vs STRA Comparison

Compare HRMY & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$33.41

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

STRA

Strategic Education Inc.

HOLD

Current Price

$75.34

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
STRA
Founded
2017
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
HRMY
STRA
Price
$33.41
$75.34
Analyst Decision
Buy
Buy
Analyst Count
9
3
Target Price
$44.11
$87.00
AVG Volume (30 Days)
718.4K
203.1K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
3.04%
EPS Growth
7.97
15.85
EPS
0.55
1.48
Revenue
$868,453,000.00
$997,137,000.00
Revenue This Year
$19.75
$4.71
Revenue Next Year
$12.88
$4.67
P/E Ratio
$60.29
$50.49
Revenue Growth
21.51
57.23
52 Week Low
$25.52
$69.70
52 Week High
$40.87
$88.50

Technical Indicators

Market Signals
Indicator
HRMY
STRA
Relative Strength Index (RSI) 54.50 39.73
Support Level $31.61 $75.10
Resistance Level $35.47 $83.97
Average True Range (ATR) 1.14 2.20
MACD 0.02 -0.54
Stochastic Oscillator 49.14 23.42

Price Performance

Historical Comparison
HRMY
STRA

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

Share on Social Networks: